The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis (original) (raw)
Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database
Michael Duffy
Annals of Oncology, 2008
View PDFchevron_right
Is the expression of matrix metalloproteinases (MMP-2, -9) and tissue inhibitors of metalloproteinases (TIMP-1, -2, and -3) associated with angiogenesis and clinicopathological features for breast cancer
Journal of Health Sciences
View PDFchevron_right
DETERMINATION OF SERUM MATRIX METALLOPROTEINASE 2 AND 9 (MMP-2) (MMP-9) IN BREAST CANCER INVASION AND METASTASIS.
IJAR Indexing
International Journal of Advanced Research (IJAR), 2019
View PDFchevron_right
Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast
Bedri Kandemir
Pathology - Research and Practice, 2011
View PDFchevron_right
Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients
Irena Ranogajec, Jelka Gabrilovac
Medical Oncology, 2011
View PDFchevron_right
Prognostic Significance of Tissue Inhibitor of Metalloproteinase-1 in Breast Cancer
John Mackey
International Journal of Breast Cancer, 2012
View PDFchevron_right
Expression of matrix metalloproteinases inhuman breast cancer tissues
Dinesh Babu Somasundaram, Benson C Selvanesan
View PDFchevron_right
Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and Prognosis
Natheer Al-Rawi
Clinical Cancer Research, 2004
View PDFchevron_right
Tumor-Derived Matrix Metalloproteinase-13 (MMP-13) Expression in Benign and Malignant Breast Lesions
Fereshteh Ameli
Asian Pacific journal of cancer prevention : APJCP, 2021
View PDFchevron_right
Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancer
Helal Abu-El-Zahab
2011
View PDFchevron_right
MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors
Cristina Dragomir
Journal of Cellular and Molecular Medicine, 2006
View PDFchevron_right
What does matrix metalloproteinase-1 expression in patients with breast cancer really tell us?
Ferdinando Mannello
BMC Medicine, 2011
View PDFchevron_right
Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse
Luis González
British journal of cancer, 2007
View PDFchevron_right
Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients
Maroulio Talieri, Theoni Trangas
British journal of cancer, 2001
View PDFchevron_right
Increased serum level of membrane type 1-matrix metalloproteinase (MT1-MMP/MMP-14) in patients with breast cancer
M. Wojtukiewicz
Folia Histochemica et Cytobiologica, 2010
View PDFchevron_right
The concentration of matrix metalloproteinase 9 in the tumor and peritumoral tissue as prognostic marker in breast cancer patients
jovana jovankic
Vojnosanitetski pregled
View PDFchevron_right
Matrix Metalloproteinases MMP 2 and MMP 9 Expression in Stages II-III Breast Cancer in Iraqi Women
Dr.Nahi Y Yaseen
2015
View PDFchevron_right
Study of matrix metalloproteinases and their inhibitors in breast cancer
Noe Vazquez
British Journal of Cancer, 2007
View PDFchevron_right
Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer
Franky Shah
Indian Journal of Cancer, 2009
View PDFchevron_right
Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome
Eleni Mylona
Breast Cancer …, 2006
View PDFchevron_right
Prognostic Value of the Matrix Metalloproteinase-9 and Its Relation to Clinicopathological Features in Women with Invasive Breast Cancer
Ahmed Elzawawy
Journal of Cancer Therapy, 2020
View PDFchevron_right
Plasma levels of matrix metalloproteinases 2 and 9 correlate with histological grade in breast cancer patients
Renata Dellalibera-joviliano
Oncology letters, 2013
View PDFchevron_right
Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast
J. Vazquez
Histopathology, 2008
View PDFchevron_right
Preoperative Serum Levels of Matrix Metalloproteinase-2 (MMP-2) and Survival of Breast Cancer among Korean Women
Keun-young Yoo
Cancer Epidemiology, Biomarkers & Prevention, 2012
View PDFchevron_right
Matrix Metalloproteinases and Their Role in Breast Cancer: A Mini Review
Rumana Ahmad
Era's Journal of Medical Research, 2019
View PDFchevron_right